These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8778156)

  • 1. Effect of two beta 2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis.
    Giustina A; Malerba M; Bresciani E; Desenzani P; Licini M; Zaltieri G; Grassi V
    J Endocrinol Invest; 1995 Dec; 18(11):847-52. PubMed ID: 8778156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
    Malerba M; Boni E; Romagnoni G; Filippi B; Politi A; Giustina A; Tantucci C; Grassi V
    Monaldi Arch Chest Dis; 1994 Dec; 49(5):389-93. PubMed ID: 7841973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response comparison of broxaterol and salbutamol pressurized aerosols.
    Simone P; Borgia M; Torre L; Ventresca GP
    Eur J Clin Pharmacol; 1990; 39(6):565-8. PubMed ID: 1982761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the beta 2 adrenoceptor partial agonist/antagonist activity of salbutamol in states of low and high adrenergic tone.
    Grove A; McFarlane LC; Lipworth BJ
    Thorax; 1995 Feb; 50(2):134-8. PubMed ID: 7701450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
    Löfdahl CG; Sigvaldasson A; Skoogh BE; Svedmyr N
    Respiration; 1989; 55 Suppl 2():15-9. PubMed ID: 2572036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of broxaterol (vs salbutamol) in asthma induced by physical exercise in children].
    Corrias A; Pelosi U; Corona GB; Minelli R; Peri M; Corda R
    Pediatr Med Chir; 1989; 11(2):161-3. PubMed ID: 2569730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man.
    Arvat E; Gianotti L; Ramunni J; DiVito L; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 1996 Jan; 19(1):25-9. PubMed ID: 8851688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the bronchodilator effects of broxaterol and salbutamol.
    Casali L; Rossi A; Manazza P; Colombo ML; Zoia MC
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):93-7. PubMed ID: 2900816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ineffectiveness of intravenous beta 2-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction.
    Malerba M; Boni E; Tantucci C; Filippi B; Romagnoni G; Grassi V
    Respiration; 1996; 63(1):8-16. PubMed ID: 8833987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of broxaterol in bronchial hyperresponsiveness.
    Bianco S
    Respiration; 1989; 55 Suppl 2():20-7. PubMed ID: 2572037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broxaterol increases force output of fatigued canine diaphragm more than salbutamol.
    Derom E; Gayan-Ramirez G; Gurrieri G; de Bock V; Decramer M
    Am J Respir Crit Care Med; 1997 Jan; 155(1):181-5. PubMed ID: 9001309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutical doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children.
    Ghigo E; Valetto MR; Gaggero L; Visca A; Valente F; Bellone J; Castello D; Camanni F
    J Endocrinol Invest; 1993 Apr; 16(4):271-5. PubMed ID: 8514982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol.
    Rampulla C; Corsico R; Majani U; Lodola E
    Respiration; 1985; 47(4):299-302. PubMed ID: 2861630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute salbutamol intake during supramaximal exercise in women.
    Le Panse B; Arlettaz A; Portier H; Lecoq AM; De Ceaurriz J; Collomp K
    Br J Sports Med; 2007 Jul; 41(7):430-4. PubMed ID: 17264145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of short-term oral salbutamol administration on exercise endurance and metabolism.
    Collomp K; Candau R; Lasne F; Labsy Z; Préfaut C; De Ceaurriz J
    J Appl Physiol (1985); 2000 Aug; 89(2):430-6. PubMed ID: 10926623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effect of oral salbutamol on growth hormone secretion in prepubertal asthmatic children.
    Lanes R; Duran Z; Aguirre J; Espina L; Alvarez W; Villaroel O; Zdanowicz M
    Metabolism; 1995 Feb; 44(2):149-51. PubMed ID: 7869909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of salbutamol and galanin on both basal and growth hormone releasing hormone-stimulated growth hormone secretion in humans.
    Arvat E; Ramunni J; Gianotti L; Di Vito L; Maccario M; Camanni F; Ghigo E
    J Endocrinol Invest; 1995 May; 18(5):324-8. PubMed ID: 7594218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol.
    Perruchoud AP; Bründler H; Godly R; Imhof E; Herzog H
    Respiration; 1987; 51(2):113-8. PubMed ID: 2884706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled salbutamol decreases blood ammonia levels during exercise in normal subjects.
    Matthys D; Calders P; Pannier JL
    Eur J Appl Physiol Occup Physiol; 1998 Dec; 79(1):110-3. PubMed ID: 10052670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta 2-adrenoceptor agonists on plasma potassium and cardiopulmonary responses on exercise in patients with chronic obstructive pulmonary disease.
    Yang CT; Lin HC; Lin MC; Wang CH; Lee CH; Kuo HP
    Eur J Clin Pharmacol; 1996; 49(5):341-5. PubMed ID: 8866625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.